Myalept

(Metreleptin)

Check Drug InteractionsCheck known drug interactions.

PrescriberAI is currently offline. Try again later.

By using PrescriberAI, you agree to the AI Terms of Use.

This AI tool offers medical information for informational purposes only and is not a substitute for professional medical judgment or advice. Physicians and healthcare professionals should exercise their expertise and discretion when interpreting and applying the provided information to specific clinical situations.

Myalept Prescribing Information

Anti-metreleptin antibodies with neutralizing activity have been identified in patients treated with MYALEPT. The consequences of these neutralizing antibodies are not well characterized but could include inhibition of endogenous leptin action and/or loss of MYALEPT efficacy. Severe infection and/or worsening metabolic control have been reported. Test for anti-metreleptin antibodies with neutralizing activity in patients who develop severe infections or show signs suspicious for loss of MYALEPT efficacy during treatment. Contact Amryt Pharmaceuticals DAC at 1-866-216-1526 for neutralizing antibody testing of clinical samples [see

4.1 General Obesity

MYALEPT is contraindicated in patients with general obesity not associated with congenital leptin deficiency. MYALEPT has not been shown to be effective in treating general obesity, and the development of anti-metreleptin antibodies with neutralizing activity has been reported in obese patients treated with MYALEPT [see

Warnings and Precautions (5.1)

and

5.1 Risk for Development of Antibodies that Neutralize Endogenous Leptin and/or MYALEPT

Anti-metreleptin antibodies with

in vitro

neutralizing activity to leptin associated with adverse events consistent with loss of endogenous leptin activity and/or loss of efficacy have been identified in two patients with generalized lipodystrophy treated with MYALEPT (severe infections, increases in HbA_1cand triglycerides), and in three patients without lipodystrophy who received MYALEPT in clinical studies (excessive weight gain, development of glucose intolerance or diabetes mellitus). The clinical implications associated with development of anti-metreleptin antibodies with neutralizing activity are not well characterized at this time due to the small number of reports. Test for anti-metreleptin antibodies with neutralizing activity in patients who develop severe infections or show signs suspicious for loss of MYALEPT efficacy during treatment. Contact Amryt Pharmaceuticals DAC at 1-866-216-1526 for neutralizing antibody testing of clinical samples [see

Adverse Reactions (6.2)

T-cell lymphoma has been reported in patients with acquired generalized lipodystrophy, both treated and not treated with MYALEPT. Carefully consider the benefits and risks of treatment with MYALEPT in patients with significant hematologic abnormalities and/or acquired generalized lipodystrophy [see

5.2 Lymphoma

Three cases of T-cell lymphoma have been reported in the MYALEPT lipodystrophy program; all three patients had acquired generalized lipodystrophy. Two of these patients were diagnosed with peripheral T-cell lymphoma while receiving MYALEPT. Both had immunodeficiency and significant hematologic abnormalities including severe bone marrow abnormalities before the start of MYALEPT treatment. A separate case of anaplastic large cell lymphoma was reported in a patient receiving MYALEPT who did not have hematological abnormalities before treatment.

Lymphoproliferative disorders, including lymphomas, have been reported in patients with acquired generalized lipodystrophy not treated with MYALEPT. A causal relationship between MYALEPT treatment and the development and/or progression of lymphoma has not been established. Acquired lipodystrophies are associated with autoimmune disorders, and autoimmune disorders are associated with an increased risk of malignancies including lymphomas.

The benefits and risks of MYALEPT treatment should be carefully considered in patients with acquired generalized lipodystrophy and/or those with significant hematologic abnormalities (including leukopenia, neutropenia, bone marrow abnormalities, lymphoma, and/or lymphadenopathy).

Because of these risks associated with the development of anti-metreleptin antibodies that neutralize endogenous leptin and/or MYALEPT and the risk for lymphoma, MYALEPT is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the MYALEPT REMS PROGRAM [see

5.3 MYALEPT REMS Program

MYALEPT is available only through a restricted distribution program under a REMS, called the MYALEPT REMS Program, because of the risks associated with the development of anti-metreleptin antibodies that neutralize endogenous leptin and/or MYALEPT and the risk for lymphoma [see

Warnings and Precautions (5.1, 5.2)

Notable requirements of the MYALEPT REMS Program include the following:

Prescribers must be certified with the program by enrolling and completing training.
Pharmacies must be certified with the program and only dispense MYALEPT after receipt of the MYALEPT REMS Prescription Authorization Form for each new prescription.

Further information is available at

www.myaleptrems.com

or 1-855-669-2537.

No formal drug interaction studies were performed.

Leptin is a cytokine and may have the potential to alter the formation of cytochrome P450 (CYP450) enzymes. This should be taken into account when prescribing concomitant drugs metabolized by CYP450 (e.g., oral contraceptives and drugs with a narrow therapeutic index). The effect of metreleptin on CYP450 enzymes may be clinically relevant for CYP450 substrates with narrow therapeutic index, where the dose is individually adjusted. Upon initiation or discontinuation of MYALEPT, in patients being treated with these types of agents, therapeutic monitoring of effect (e.g., warfarin) or drug concentration (e.g., cyclosporine or theophylline) should be performed and the individual dose of the agent adjusted as needed.

MYALEPT (metreleptin) for injection is a recombinant human leptin analog for injection that binds to and activates the leptin receptor. Metreleptin (recombinant methionyl-human leptin) is produced in

E. coli

and differs from native human leptin by the addition of a methionine residue at its amino terminus. Metreleptin is a 147-amino acid, nonglycosylated, polypeptide with one disulfide bond between Cys-97 and Cys-147 and a molecular weight of approximately 16.15 kDa.

MYALEPT is supplied as a sterile, white, solid, lyophilized cake containing 11.3 mg that is reconstituted with 2.2 mL of BWFI or WFI to a final formulation of 5 mg/mL metreleptin for subcutaneous injection. Inactive ingredients are: glutamic acid (1.47 mg/mL), glycine (20 mg/mL), polysorbate 20 (0.1 mg/mL), and sucrose (10 mg/mL), pH 4.25.

Instructions for Use

MYALEPT^® (MAI-uh-lept)

(metreleptin) for injection, for subcutaneous use

Vial

A healthcare provider should show you how to inject MYALEPT before you use it for the first time. A healthcare provider should also watch you inject your MYALEPT dose the first time you inject it.
Do not
inject MYALEPT until your healthcare provider has shown you the right way to inject it. If you have questions or do not understand the instructions, talk to your healthcare provider or pharmacist.
MYALEPT is
only
for use under the skin (subcutaneous).
Do not
share your MYALEPT needles with another person. You may give an infection to them, or get an infection from them.

This Instructions for Use is divided into 6 steps:

Step 1: Getting started

Step 2: Filling the 3 mL syringe with 2.2 mL of liquid

Step 3: Preparing MYALEPT

Step 4: Filling the syringe used for injecting MYALEPT

Step 5: Injecting MYALEPT

Step 6: Disposing of used needles and syringes

If at any time during these steps you have questions:

See the "Common Questions" tab
Call 1-855-669-2537
Visit
www.MYALEPT.com

Supplies you will need to give your MYALEPT (see Figure A).

Make sure you have all the supplies listed below BEFORE using MYALEPT.

You can get these supplies with a prescription from your healthcare provider, from a retail or hospital pharmacy, or the specialty pharmacy that distributes MYALEPT.

a vial with liquid for mixing MYALEPT
- Sterile water for injection should be used in newborns and infants
- Bacteriostatic water for injection should be used for older children and adults
a 3 mL syringe with a longer needle for mixing MYALEPT
a vial with MYALEPT powder
a 1 mL syringe (or smaller) with a shorter needle for injecting MYALEPT
2 alcohol wipes
1 sharps container for throwing away used needles and syringes. See "
Disposing of used needles and syringes
" at the end of these instructions.
Stickers to note discard date for mixed medicine

How to read your syringes:

The 3 mL syringe has a longer needle (see Figure B).

The 3 mL syringe is the syringe you will use to mix MYALEPT.

Always fill the 3 mL syringe with 2.2 mL of liquid.

Do not

inject yourself with the 3 mL syringe.

Figure B

The injection syringes have a shorter needle (see Figure C).

People who weigh more than 88 pounds (lbs) (40 kg) should use a 1 mL syringe to administer their injection of MYALEPT. People who weigh 88 lbs (40 kg) or less should use either a 1 mL or smaller syringe because smaller amounts of MYALEPT are needed for injection. Using the wrong size syringe can cause you to measure the wrong amount of MYALEPT.

The 1 mL (or smaller) syringe is the syringe you will use to inject MYALEPT.

Only use the 1 mL (or smaller) syringe to inject your dose of MYALEPT.

Step 1: Getting Started

Your dose of MYALEPT may change over time, depending on how MYALEPT works for you. So it is important to keep track of your dose. On the line below, write down your dose in mL and the date. Be sure to keep this up-to-date if your dose changes:

Take 1 MYALEPT vial out of the refrigerator 10 minutes before you plan to inject to allow it to reach room temperature.
Set 1 vial with the liquid you will need to mix MYALEPT on your work surface.
Check the powder in the MYALEPT vial. It should be white.
Do not
use MYALEPT if the powder is discolored. Throw it away and get a new one.
Check the expiration date printed on the MYALEPT vial.
Do not
use MYALEPT past the expiration date printed on the vial
(see Figure D)
.

Figure D

For this step, you will need:

Vial with liquid for mixing

a dose of MYALEPT

Referenced Image

Vial with powder

(MYALEPT)

Referenced Image

Alcohol wipes

Referenced Image

Wash your hands with soap and water.

Remove 2 alcohol wipes from their wrappers.

Place the wipes on their wrappers to keep them clean.

Use your thumb to remove the caps from the vials.

Clean the tops of the vials with one of the alcohol wipes.

STEP 2: Filling the 3 mL syringe (used to mix MYALEPT) with 2.2 mL of liquid

For this step, you will need:

A 3 mL syringe (with longer needle) used to mix MYALEPT

Vial with liquid

(from Step 1)

Sharps disposal container

Take the 3 mL syringe out of the plastic wrapper. Always use a new syringe.

Pull the needle cover straight off.

Do not

twist the needle when removing the cover.

Put the needle cover in the sharps disposal container.

Pull down the plunger to fill the syringe with air.

You

must first

fill the syringe with air and put that air into the vial to make it easier to later fill the syringe with liquid.

Line up the top rim of the plunger with the black 2.2 mL line.

Set the vial with the liquid on the work surface. Insert the needle into the top of the vial.

Push the plunger down all the way to fill the vial with air.

With the needle still in the vial, turn the vial and syringe upside down.

Keep the whole needle in the liquid.

Pull down the plunger until the top rim of the plunger lines up with the black 2.2 mL line.

Check to see if there is an air pocket in the syringe.

If you see an air pocket, tap the side of the syringe to move the air pocket to the top of the syringe.

Push the plunger up to remove the air pocket.

You must remove the air pocket to be able to fill the syringe with 2.2 mL of liquid.

Tip: You will always fill the 3 mL syringe with 2.2 mL of liquid.

Check to see if there are large air bubbles in the syringe.

If you see large air bubbles in the syringe, tap the syringe to move the air bubbles to the top.

If there are a few small bubbles left, that is okay.

Push the plunger up to remove as many large air bubbles as you can.

Pull down the plunger so the top rim of the plunger lines up with the black 2.2 mL line.

Keep the whole needle in the liquid.

Remove the needle from the vial. Be careful not to move the plunger.

Keep the syringe in your hand.

Do not

set it down.

For instructions on how to discard the used vial of liquid, read the carton that contained those vials.

STEP 3: Preparing MYALEPT

Note: If you already mixed your MYALEPT before today, go to "Using a vial of mixed MYALEPT" at the end of this step.

Option 1: Mixing a new vial of MYALEPT:

For this step, you will need:

The 3 mL syringe filled with 2.2 mL of liquid (from Step 2)

Vial with powder (from Step 1)

Sharps disposal container

Set the vial with the MYALEPT powder on the work surface. Insert the needle straight down into the center of the vial.

Then tilt the vial so that the tip of the needle is pointing toward the inside wall of the vial.

With your thumb,

slowly

push the plunger down all the way.

The liquid should go down the inside wall of the vial.

Make sure you add the liquid slowly so that bubbles do not form in the vial.

No liquid should be left in the syringe.

While keeping the plunger all the way down, take the needle out of the vial.

Throw away the syringe with the needle still attached into your sharps disposal container.

Do not

recap the needle. Recapping the needle can lead to a needlestick injury.

To mix the powder and liquid,

move the vial gently in a circle

(swirl) until the liquid is clear. Do not shake the vial.

When the medicine is mixed well, the liquid should be clear. You should not see any clumps, powder, bubbles, or foam.

Tip: If your vial of MYALEPT is not mixed well, go back to Step 3c.

Note: Go to Step 4 if you just mixed a new vial of MYALEPT.

Option 2: Using a vial of mixed MYALEPT:

Note: For newborns or infants using MYALEPT, throw away any unused mixed MYALEPT right away. Do not store it for reuse.

For this step, you will need:

Vial of mixed MYALEPT

Alcohol wipes

Choose a clean, flat work surface large enough to let you prepare the medicine.

Take 1 vial of mixed MYALEPT out of the refrigerator.

Only MYALEPT mixed with bacteriostatic water for injection can be stored for reuse.

You must use the vial within 2 days after the day the medicine was mixed.

Set the vial of mixed MYALEPT on the work surface for 10 to 15 minutes so that it comes to room temperature.

Wash your hands with soap and water.

Remove 2 alcohol wipes from their wrappers.

Place the wipes on their wrappers to keep them clean.

Clean the top of the vial with the alcohol wipe.

Check that the MYALEPT is mixed well and is clear. You should not see any clumps, powder, bubbles, or foam.

If you see clumps, powder, bubbles, or foam, throw away the vial in the sharps disposal container.

Important:

Do not mix any liquid or mixed medicine from another vial with the vial you just cleaned.

STEP 4: Filling the syringe used for injecting MYALEPT

Patients greater than 40 kg should use a 1 mL syringe for administration. In pediatric patients, small volumes for administration can result in medication errors when measured incorrectly. Smaller syringe sizes may be more appropriate for pediatric patients weighing less than or equal to 25 kg. Ensure the proper size syringe is selected.

The table below shows how a dose of MYALEPT (mg) is converted to solution volume (mL) and the injection syringe marks (units) that correspond with the dose.

Conversion of MYALEPT Dose to Unit Measurement for Injection
DOSE OF MYALEPT	AMOUNT OF MIXED MYALEPT SOLUTION TO INJECT (TUBERCULIN SYRINGE USERS)	AMOUNT OF MIXED MYALEPT SOLUTION TO INJECT (INSULIN SYRINGE USERS)
0.30 mg	0.06 mL	6 units
0.36 mg	0.07 mL	7 units
0.42 mg	0.08 mL	8 units
0.48 mg	0.09 mL	9 units
0.54 mg	0.10 mL	10 units
0.60 mg	0.12 mL	12 units
0.66 mg	0.13 mL	13 units
0.72 mg	0.14 mL	14 units
0.78 mg	0.15 mL	15 units
0.84 mg	0.16 mL	16 units
0.90 mg	0.18 mL	18 units
0.96 mg	0.19 mL	19 units
1.02 mg	0.20 mL	20 units
1.08 mg	0.21 mL	21 units
1.14 mg	0.22 mL	22 units
1.20 mg	0.24 mL	24 units
1.26 mg	0.25 mL	25 units
1.32 mg	0.26 mL	26 units
1.38 mg	0.27 mL	27 units
1.44 mg	0.28 mL	28 units
1.50 mg	0.30 mL	30 units
1.56 mg	0.31mL	31 units
1.62 mg	0.32 mL	32 units
1.68 mg	0.33 mL	33 units
1.74 mg	0.34 mL	34 units
1.80 mg	0.36 mL	36 units
1.86 mg	0.37 mL	37 units
1.92 mg	0.38 mL	38 units
1.98 mg	0.39 mL	39 units
2.04 mg	0.40 mL	40 units
2.10 mg	0.42 mL	42 units
2.16 mg	0.43 mL	43 units
2.22 mg	0.44 mL	44 units
2.28 mg	0.45 mL	45 units
2.34 mg	0.46 mL	46 units
2.40 mg	0.48 mL	48 units
2.5 mg	0.50 mL	50 units
3.75 mg	0.75 mL	75 units
5.00 mg	1.00 mL	100 units
6.25 mg	1.25 mL	125 units
7.50 mg	1.5 mL	150 units

8.75 mg	1.75 mL	175 units
10.00 mg	2.00 mL	200 units

For this step, you will need:

A (1 mL or smaller) syringe (with shorter needle) used to inject MYALEPT

Examples:

Vial of mixed MYALEPT (from Step 3)

Sharps disposal container

Referenced Image Remove the injection syringe from the plastic wrapper. Always use a new syringe.

Firmly grip the needle base.

Pull the needle cover straight off.

Throw away the needle cover in the sharps disposal container.

Pull down the plunger until the top rim of the plunger lines up with the black line of the dose prescribed by your healthcare provider.

You

must first

fill the syringe with air and put that air into the vial to make it easier to later fill the syringe with liquid.

Hold the vial with the mixed MYALEPT. Insert the needle into the top of the MYALEPT vial.

Push the plunger down all the way, to fill the vial with air.

With the needle still in the vial, turn the vial and syringe upside down.

Keep the whole needle in the liquid. It is okay if the plunger moves down.

Pull down the plunger until the top rim of the plunger lines up with the black line of the dose prescribed by your healthcare provider.

Check to see if there is an air pocket in the syringe.

If you see an air pocket, tap the side of the syringe to move the air pocket to the top of the syringe.

Push the plunger up to remove the air pocket.

You must remove the air pocket to be able to fill the syringe with a full dose of MYALEPT.

Tip: If your prescribed dose is more than 1 mL, you will need to use 2 separate injections to take your full daily dose. Repeat Step 4 to fill the second syringe.

Check to see if there are large air bubbles in the syringe.

If you see large air bubbles in the syringe, tap the side of the syringe to move the air bubbles to the top.

If there are a few small bubbles left, that is okay.

Push the plunger up to remove as many large air bubbles as you can.

Pull down the plunger again until the top rim of the plunger lines up with the black line of the dose prescribed by your healthcare provider.

Remove the needle from the vial.

Set the vial down.

Do not

set the syringe down.

STEP 5: Injecting MYALEPT

For this step, you will need:

Syringe filled with your

MYALEPT dose

(from Step 4)

Alcohol wipe

(from Step 1)

Sharps disposal

container for used syringes and needles

Choose an injection site that you will use to inject your MYALEPT.

The recommended injection sites are an area of your body that has the most fat, such as the stomach (abdomen), thigh, or the back of your upper arm.

You can use the same area of the body for each injection. But be sure to choose a different injection site in that area.

If you inject other medicines you should choose a different site from where you inject MYALEPT.

Do not

inject MYALEPT in the same site as your other medicines.

Use an alcohol wipe to clean the injection site.

Let the alcohol dry before you move on to 5c.

Pinch the skin with one hand.

With the other hand, hold the syringe like a pencil.

Insert the needle into the skin at an angle.

Do not

insert the needle straight up and down.

Let go of the skin.

Use your thumb to push the plunger down until it stops.

Take the needle out of your skin.

Important:

Inject MYALEPT under the skin (subcutaneous).

Do not

inject MYALEPT into a muscle or vein.

Throw away the used syringe with the needle still attached in your sharps disposal container. See "

Disposing of used needles and syringes

" at the end of this IFU.

Do not

recap the needle. Recapping the needle can lead to a needlestick injury.

Important:

Unused MYALEPT mixed with sterile water for injection (newborns or infants),

must be thrown away.

Do not

store it for reuse.

MYALEPT mixed with bacteriostatic water for injection can be stored for reuse.

Store the vial of mixed MYALEPT in the refrigerator as soon as you are done.

Looking at a calendar, count 2 days after the day you mixed the MYALEPT.

For example, if you mixed MYALEPT on Monday, January 2, you would throw it away

after your dose

on Wednesday, January 4.

Write that date on the stickers found to the right.

Place the sticker on the vial of mixed MYALEPT.

Important:

Stickers to Note the Last Day You Can Use MYALEPT When Mixed with Bacteriostatic Water for Injection

STEP 6: Disposing of used needles and syringes:

Put your used needles and syringes in an FDA-cleared sharps disposal container right away after use.
Do not
throw away (dispose of) loose needles and syringes in your household trash.
If you do not have an FDA-cleared sharps disposal container, you may use a household container that is:
- made of heavy-duty plastic
- can be closed with a tight-fitting, puncture-resistant lid, without sharps being able to come out
- upright and stable during use
- leak-resistant, and
- properly labeled to warn of hazardous waste inside the container
When your sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container. There may be state or local laws about how you should throw away used needles and syringes. For more information about safe sharps disposal, and for specific information about sharps disposal in the state you live in, go to the FDA's website at: http://www.fda.gov/safesharpsdisposal.

Common questions

Questions about storing and traveling with MYALEPT	page 15
Questions about preparing and mixing your dose of MYALEPT	pages 15-16
Questions about injecting MYALEPT	page 16
Questions about MYALEPT supplies	page 16

Common questions

Questions about storing and traveling with MYALEPT

How do I store a vial of powder (MYALEPT) and mixed MYALEPT?

The vial of powder has a white cap. The vial of mixed medicine is the vial to which you applied the sticker.

These vials should be kept in their carton in the refrigerator until you are ready to use them
Store these vials in their carton so they can be protected from light
Do not freeze or heat these vials

How long can I leave a vial of powder or mixed MYALEPT at room temperature?

A vial of powder or MYALEPT mixed with bacteriostatic water for injection can be left at room temperature for up to 4 hours. MYALEPT mixed with sterile water for injection should be used right away. Throw away any unused mixed MYALEPT. If you are unsure about whether you can use a vial of powder or mixed MYALEPT, call 1-855-6MYALEPT.

What do I do with a vial of powder or mixed MYALEPT if it has been frozen or heated?

If a vial of powder or mixed MYALEPT has been frozen or heated, throw it away in the sharps disposal container.

What do I do with a vial of mixed MYALEPT if there is not a full dose left?

Ask your healthcare provider how to use or store a vial of mixed MYALEPT that contains less than a full dose.

How do I take MYALEPT if I am away from home or traveling?

To take a dose of MYALEPT if you are away from home or traveling, you must take all of your supplies with you. Do not fill a syringe or prepare a dose ahead of time and take it with you.

Questions about preparing and mixing your dose of MYALEPT

6Q	What should I do if I touch the top of a vial after I have cleaned it?
A	Clean the top of the vial again with a new alcohol wipe.
7Q	What should I do if my dose is written in mg (milligrams), not mL (milliliters)?
A	If your dose of MYALEPT is written in mg and not mL, call your pharmacist. Your pharmacist can give you your dose in mL. Do not try to prepare a dose of MYALEPT if your dose is in mg.
8Q	What should I do if there are air bubbles or air pockets in the syringe?
A	Follow steps 2g (page 5) and 2h (page 6) to remove air bubbles or an air pocket from the syringe when filling it with liquid. Follow steps 4g and 4h (page 11) to remove air bubbles or an air pocket from the syringe when filling it with MYALEPT. Check to see if there are large air bubbles in the syringe. If so, tap the syringe to move the air bubbles to the top. If there are still a few small air bubbles left in the syringe after these steps, that is okay. The air bubbles will not harm you.
9Q	What if the needle comes off the syringe used to mix MYALEPT when I am trying to remove the needle cover?
A	With the needle cover still on the needle, twist the needle back onto the syringe. Firmly grip the syringe and pull the needle cover straight off. Do not twist the syringe or needle when pulling off the needle cover.
10Q	What if the needle comes off the syringe used to inject MYALEPT when I am trying to remove the needle cover?
A	With the needle cover still on the needle, firmly push the needle back onto the syringe. Grip the base of the needle as firmly as you can between your index finger and thumb while pulling on the needle cover.
11Q	What do I do if I see foam in a vial of medicine I am mixing?
A	If foam forms in the vial of medicine as you swirl it, let the vial sit on the work surface until the foam is gone.
12Q	Can I fill a syringe with a dose of mixed MYALEPT and save it to use later?
A	A dose of MYALEPT should be taken right after it is mixed. Do not fill a syringe or prepare a dose for later use.

Questions about injecting MYALEPT

13Q

What are some tips for injecting MYALEPT?

Try these tips to help you prepare for your injection with MYALEPT:

Know the steps in the process.
To get to know the steps, read this booklet ahead of time. It may help to read the steps out loud. If you have questions about how to inject, make sure to ask your healthcare provider
Find a place that is clean and well lit in which you can do the injection
Ask for help.
You may feel more comfortable if a care partner does the injection for you
Put ice on the injection site.
You may want to use ice at the injection site, after your injection, to help lessen some of the pain you might feel
Make sure the vial with powder (MYALEPT) is at room temperature before you mix and inject it.
To do this, take a vial with powder out of the refrigerator and set it out for 10 to 15 minutes

Questions about MYALEPT supplies

14Q

How do I obtain the supplies needed to inject MYALEPT?

The standard supplies needed to inject MYALEPT include needles, syringes, liquid for mixing and a disposal container. Your healthcare provider will give you a prescription for these supplies which can be filled by a retail or hospital pharmacy, or the specialty pharmacy who distributes MYALEPT.

15Q

How do I store the other supplies that are needed to prepare and inject a dose of MYALEPT?

Store syringes, vials of liquid with colored caps, alcohol wipes, and sharps disposal container at room temperature or at the temperature that is written on the package they came in. Be sure to check the expiration date on the packages of your supplies before use. Do not use expired supplies.

To learn more about MYALEPT

Talk with your healthcare provider
Read the Medication Guide that came with MYALEPT. The Medication Guide can help answer your questions about MYALEPT, such as what it is used for, possible side effects, and when to take it
Visit www.MYALEPT.com or call 1-855-6MYALEPT for FREE ongoing support and services

This Instructions for Use has been approved by the U.S. Food and Drug Administration.

Manufactured by:

Amryt Pharmaceuticals DAC

Dublin, Ireland

US License No. 2208

PN 4086-03

Issued September 2020

Adipocytes store lipids to meet the fuel requirements of non-adipose tissues during fasting. In patients with generalized lipodystrophy, the deficiency of adipose tissue leads to hypertriglyceridemia and ectopic deposition of fat in non-adipose tissues such as liver and muscle, contributing to metabolic abnormalities including insulin resistance. Native leptin is a hormone predominantly secreted by adipose tissue that informs the central nervous system of the status of energy stores in the body. In patients with generalized lipodystrophy, leptin deficiency, resulting from the loss of adipose tissue, contributes to excess caloric intake, which exacerbates the metabolic abnormalities.

MYALEPT (metreleptin) for injection exerts its function by binding to and activating the human leptin receptor (ObR), which belongs to the Class I cytokine family of receptors that signals through the JAK/STAT transduction pathway.

Myalept

Myalept Prescribing Information

Myalept Prior Authorization Resources

Most recent Myalept prior authorization forms

Most recent state uniform prior authorization forms

Benefits investigation

Myalept PubMed™ News

Myalept Patient Education

Getting started on Myalept

Patient toolkit